Select a community
All Communities
Home > Community Treatment Reports > Paxil CR (paroxetine) Treatment Report
What is Paxil CR?

Paxil CR® is a brand name for the controlled release formulation of the drug paroxetine, a serotonin-specific reuptake inhibitor (SSRI) type of anti-depressant. Read more...Click to read more below

Side Effects

Side effects as an overall problem

Severe
1 13%
Moderate
2 25%
Mild
3 38%
None
2 25%

Most commonly reported side effects

Dizziness
4 50%
Weight gain
4 50%
Insomnia
3 38%
Tremors
3 38%
Sexual dysfunction
3 38%
Memory Loss
2 25%
  • Mild
  • Moderate
  • Severe

Dosages

  12.5 mg daily 25 mg daily 37.5 mg daily 50 mg daily 75 mg daily 80 mg daily
  6 Number of Patients: 6 7 Number of Patients: 7 7 Number of Patients: 7 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Paxil CR (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
6 50% Side effects too severe: 50%
Personal research
3 25% Personal research: 25%
Doctor's advice
3 25% Doctor's advice: 25%
Other
3 25% Other: 25%
Expense
2 17% Expense: 17%
Did not seem to work
2 17% Did not seem to work: 17%
Course of treatment ended
1 8% Course of treatment ended: 8%

See all 11 patients who’ve stopped taking Paxil CR

Duration See details about how long patients take this treatment ▼

Currently Taking Paxil CR

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
1
1
9

Stopped Taking Paxil CR

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
4
4
2

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
8 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
1 13%
Somewhat
1 13%
A little
4 50%
Not at all
2 25%

Cost

Paid out of pocket

$200+
0 0%
$100-199
1 13%
$50-99
0 0%
$25-49
3 38%
< $25
1 13%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.